Evidence map›Paper›PMID 37904915›Full record

ArticlebioRxiv : the preprint server for biology2023

Negative Binomial Mixture Model for Identification of Noise in Antigen-Specificity Predictions by LIBRA-seq.

Perry T Wasdin, Alexandra A Abu-Shmais, Michael W Irvin, Matthew J Vukovich, Ivelin S Georgiev

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Perry T WasdinProgram in Chemical and Physical Biology, Vanderbilt University Medical Center; Nashville, TN, USA.
Alexandra A Abu-ShmaisVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Michael W IrvinData Science and Learning Division, Argonne National Laboratory, Lemont, Illinois, USA.
Matthew J VukovichVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Ivelin S GeorgievProgram in Chemical and Physical Biology, Vanderbilt University Medical Center; Nashville, TN, USA.
Nashville Oncology Associates · USVanderbilt University Medical Center · USArgonne National Laboratory · US

Funding

Vanderbilt Biomedical Informatics Training ProgramT15LM007450 · NLM · VANDERBILT UNIVERSITY · PI Jessica S. Ancker, Bradley A. Malin · 2002 to 2026
$19.7M
Chemical Biology of Infectious Diseases (CBID) Training ProgramT32AI112541 · NIAID · VANDERBILT UNIVERSITY · PI Eric P Skaar · 2015 to 2026
$4.0M
Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor SequenceR01AI175245 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ivelin Georgiev · 2023 to 2026
$3.4M
NIAID NIH HHS R01 AI175245NIAID NIH HHS T32 AI112541NLM NIH HHS T15 LM007450
6 · The paper itself

Abstract

Motivation: LIBRA-seq (linking B cell receptor to antigen specificity by sequencing) provides a powerful tool for interrogating the antigen-specific B cell compartment and identifying antibodies against antigen targets of interest. Identification of noise in LIBRA-seq antigen count data is critical for improving antigen binding predictions for downstream applications including antibody discovery and machine learning technologies. Results: In this study, we present a method for denoising LIBRA-seq data by clustering antigen counts into signal and noise components with a negative binomial mixture model. This approach leverages the VRC01 negative control cells included in a recent LIBRA-seq study(Abu-Shmais

Identifiers

PMID37904915
PMCPMC10614817
OpenAlexW4387729808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.